Salicylism from Topical Salicylates: Review of the Literature

References

• Maurer T. A., Winter M. E., Koo J., Berger T. G. Refractory hypoglycemia: a complication of topical salicylate therapy. Arch Dermatol 1994; 130: 1455–1457
   PubMed Web of Science ®Google Scholar
• Gip L., Hamfelt A. Percutaneous absorption of betamethasone-17, 21 dipropionate and salicylic acid during the treatment of psoriasis and eczema. J Jnt Med Res 1976; 4: 106–110
   Web of Science ®Google Scholar
• Davies M. G., Briffa D. V., Greaves M. W. Systemic toxicity from topically applied salicylic acid. BMJ 1979; 1: 661
   PubMed Web of Science ®Google Scholar
• Roberts M. S., Favretto W. A., Meyer A., Reckmann M., Wongseelashote T. Topical bioavailability of methyl salicylate. Aust NZJ Med 1982; 12: 303–305
   PubMedGoogle Scholar
• Heng M. C. Local necrosis and interstitial nephritis due to topical methyl salicylate and menthol. Cutis 1987; 39: 442–444
   PubMed Web of Science ®Google Scholar
• Rose F. A., Wiemer D. R. Platelet coagulopathy secondary to topical salicylate use. Ann Plast Surg 1983; 11: 340–343
   PubMed Web of Science ®Google Scholar
• Oziomek R. S., Perrin D. H., Herold D. A., Denegar C. R. Effect of phonophoresis on serum salicylate levels. Med Sci Sports Exerc 1991; 23: 397–401
   PubMed Web of Science ®Google Scholar
• Lotte C., Wester R. C., Rougier A., Maibach H. I. Racial differences in the in vivo percutaneous absorption of some organic compounds: a comparison between black, Caucasian and Asian subjects. Arch Dermatol Res 1993; 284: 456–459
   PubMed Web of Science ®Google Scholar
• Guy R. H., Hadgraft J. Structure-activity correlations in percutaneous absorption. Percutaneous Absorption: Mechanisms-Methodology-DrugDelivery2nd ed., R. L. Bronaugh, H. I. Maibach. Marcel Dekker, New York 1989; 95–109
   Google Scholar
• Rougier A., Dupuis D., Lotte C., Maibach H. I. Stripping method for measuring percutaneous absorption in vivo. Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery2nd ed., R. L. Bronaugh, H. I. Maibach. Marcel Dekker, New York 1989; 415–434
   Google Scholar
• Wester R. C., Maibach H. I. Dermal decontamination and percutaneous absorption. Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery2nd ed., R. L. Bronaugh, H. I. Maibach. Marcel Dekker, New York 1989; 335–342
   Google Scholar
• Bailey R. B., Jones S. R. Chronic salicylate intoxication. A common cause of morbidity in the elderly. J Am Geriatr Soc 1989; 37: 556–561
   PubMed Web of Science ®Google Scholar
• Anderson R. J., Potts D. E., Gabow P. A., Rumack B. H., Schrier R. W. Unrecognized adult salicylate intoxication. Ann Intern Med 1976; 85: 745–748
   PubMed Web of Science ®Google Scholar
• Roskos K. V., Maibach H. I., Guy R. H. The effect of aging on percutaneous absorption in man. J PharmacoMnet Biopharm 1989; 17: 617–630
   PubMedGoogle Scholar
• Danon A., Ben-Shimon S., Ben-Zvi Z. Effect of exercise and heat exposure on percutaneous absorption of methyl salicylate. Eur J Clin Pharmacol 1986; 31: 49–52
   PubMed Web of Science ®Google Scholar
• Sanchez M. R. Dermatologic principles. Goldfrank's Toxicologic Emergencies5th ed., L. R. Goldfrank, N. E. Flomenbaum, N. A. Lewin, et al. Appleton and Lange, Norwalk Connecticut 1994; 319–344
   Google Scholar
• Von Weiss J. F., Lever W. F. Percutaneous salicylic acid intoxication in psoriasis. Arch Dermatol 1964; 190: 614–619
   Google Scholar
• Raschke R., Arnold-Capell P. A., Richeson R., Curry S. C. Refractory hypoglycemia secondary to topical salicylate intoxication. Arch Intern Med 1991; 151: 591–593
   PubMed Web of Science ®Google Scholar
• Taylor J. R., Halprin K. M. Percutaneous absorption of salicylic acid. Arch Dermatol 1975; 111: 740–743
   PubMed Web of Science ®Google Scholar
• Gross H., Greenberg L. A. Salicylates: Critical Bibliographic Review. Hillhouse Press, New Haven, Connecticut 1948
   Google Scholar
• Summons W. H. Clinical notes: Case 1. Poisoning from skin absorption of salicylic acid. Intercolon Med J 1904; 518–519
   Google Scholar
• Young C. J. Salicylate intoxication from cutaneous absorption of salicylic acid. South Med J 1952; 145: 1075–1077
   Google Scholar
• Cawley E. P., Peterson N. T., Wheeler C. E. Salicylic acid poisoning in dermatological therapy. JAMA 1953; 151: 372–374
   PubMed Web of Science ®Google Scholar
• Lindsey C. P. Two cases of fatal salicylate poisoning after topical application of an antifungal solution. MedJAus 1968; 1: 353–354
   Google Scholar
• Anderson J. A., Ead R. D. Percutaneous salicylate poisoning. Oin Exp Dermatol 1979; 4: 349–351
   PubMed Web of Science ®Google Scholar
• Smith W. O., Lyons D. Metabolic acidosis associated with percutaneous absorption of salicylic acid. J Okla State Med Assoc 1980; 73: 7–8
   PubMedGoogle Scholar
• Dwyer C. M., McCloskey R. H., Keri R. E. Poisoning from topical salicylic acid. Postgrad Med J 1994; 70: 146
   PubMed Web of Science ®Google Scholar
• Ward P. S., Jones R. D. Successful treatment of a harlequin fetus. Arch Dis Child 1989; 64: 1309–1311
   PubMed Web of Science ®Google Scholar
• Shupp D. L., Schroeter A. L. An unusual case of salicylate toxicity. J Am Acad Dermatol 1986; 15: 300–301
   PubMed Web of Science ®Google Scholar
• Aspinail J. B., Goel K. M. Salicylate poisoning in dermatological therapy. BMJ 1978; 2: 1373
   Web of Science ®Google Scholar
• Galea P., Goel K. M. Salicylate poisoning in dermatological treatment. Arch Dis Child 1990; 65: 335
   PubMed Web of Science ®Google Scholar